Claims
- 1. A method for treating persons suffering from acute or chronic degenerative conditions or diseases of the eye which comprises administering a pharmaceutically effective amount of a histone deacetylase inhibitor.
- 2. The method of claim 1 wherein the condition or disease is selected from the group consisting of: glaucoma; dry AMD; RP and other forms of heredodegenerative retinal disease; retinal detachment and tears; macular pucker; ischemia affecting the outer retina; cellular damage associated with diabetic retinopathy and retinal ischemia; damage associated with laser therapy (grid, focal, and panretinal) including photodynamic therapy (PDT); trauma; surgical (retinal translocation, subretinal surgery, or vitrectomy) or light-induced iatrogenic retinopathy; and preservation of retinal transplants.
- 3. The method of claim 2 wherein the condition or disease is dry AMD.
- 4. The method of claim 2 wherein the condition or disease is glaucoma.
Parent Case Info
[0001] This application claims priority from U.S. S. No. 60/425,576, filed Nov. 12, 2002.
Provisional Applications (1)
|
Number |
Date |
Country |
|
60425576 |
Nov 2002 |
US |